{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinsonâ€™s disease (PD) is linked to abnormal mitochondrial function, and increased levels of WT and A53T R-syn (alpha-synuclein) are associated with PD.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly connects alpha-synuclein variants to mitochondrial dysfunction in PD, establishing a clear disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "2-D difference in-gel electrophoresis (2D-DIGE) and Western blot analysis were used to compare mitochondrial proteomes between WT and A53T R-syn overexpressing cells.",
          "judgment": "Yes",
          "reasoning": "Proteomic profiling (2D-DIGE) and Western blot are established methods for studying protein expression changes relevant to mitochondrial dysfunction in neurodegenerative diseases."
        },
        {
          "step_name": "Step 3a: Basic controls/replicates",
          "extracted_paper_info": "Statistical comparisons included host cells vs. WT and host cells vs. A53T variants. ANOVA and t-tests were reported (p < 0.01, fold changes).",
          "judgment": "Yes",
          "reasoning": "The study used appropriate controls (host vs. WT/A53T) and robust statistical methods with reported p-values and fold changes, indicating sufficient replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The study compared WT and A53T variants but did not explicitly use known pathogenic/benign variants as controls.",
          "judgment": "No",
          "reasoning": "While the study compared A53T to WT, it did not use additional variant controls classified as pathogenic/benign according to ACMG criteria."
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "ANOVA (p < 0.01) and t-tests with fold changes were reported, though OddsPath was not explicitly calculated.",
          "judgment": "No",
          "reasoning": "The paper did not provide OddsPath values, but robust statistical tests (p < 0.01) and fold changes were reported."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study compared 1 (WT) and 1 (A53T) variant, totaling 2 variants. No additional controls were explicitly listed.",
          "judgment": "Yes",
          "reasoning": "Only 2 variants were compared (WT and A53T), which is below the threshold of 11 for moderate evidence."
        }
      ],
      "final_assessment": {
        "evidence_strength": "PS3_supporting",
        "reasoning": "The A53T variant showed significant mitochondrial proteomic changes (p < 0.01, fold changes) compared to WT, with robust statistical analyses. However, limited variant controls (only WT and A53T) and lack of OddsPath calculation limit the strength to 'supporting' rather than 'moderate' or 'very strong'."
      }
    }
  ]
}